[PDF] Top 20 Predicting response to epigenetic therapy
Has 10000 "Predicting response to epigenetic therapy" found on our website. Below are the top 20 most common "Predicting response to epigenetic therapy".
Predicting response to epigenetic therapy
... Recent multicenter studies demonstrated that DNMTis have sig- nificant efficacy in the treatment of hematological malignancies (5–9) and have led to the approval of two DNMTis, azacytidine and decitabine, by the FDA and ... See full document
10
Aberrant DNA Methylation in Cholangiocarcinoma
... cholangiocarcinoma. Epigenetic therapy with DNA methylation inhibitors hold considerable promise for the treatment of cholangiocarcinoma through re-activation of tumor suppressor genes and miRNAs as well as ... See full document
10
Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
... the response to anti- VEGF treatment and SNPs in components of the VEGF ...of response as it is directly proximal to the underlying pathology, that is, ... See full document
8
Harnessing the potential of epigenetic therapy to target solid tumors
... potential epigenetic therapy ...the therapy efficacy for specifically targeting these enzymes for cancer ...of epigenetic therapy if we view it as a means to broadly reprogram the ... See full document
9
<p>Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer</p>
... Previous sequencing analyses have revealed an abnor- mal expression of hsa_circ_006352 in ovarian cancer. 10 Hsa_circ_006352 is located at chr1q21.3: 150923840 – 150935195 with 1078 length in gene symbol SETDB1; thus, we ... See full document
7
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
... A dose of 400 mg sorafenib was orally administered twice a day with or without regular transcatheter arterial chemoem- bolization therapy. Dose reduction was executed according to the appearance of toxicity. If ... See full document
10
Control of viral infections by epigenetic-targeted therapy
... HCMV lytic cycle and reactivation from latency are under the control of several epigenetic mechanisms. For example, histone demethylases (HDMs), due to their ability to remove the repressive marks, will promote ... See full document
17
The value of left ventricular strain–volume loops in predicting response to cardiac resynchronization therapy
... structure, could provide unique information for predict- ing CRT response. Three-dimensional (3D) speckle tracking imaging (STI) allows the simultaneous evalu- ation of cardiac principal strain (PS) and volume ... See full document
14
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
... each epigenetic pretreatment group, we found that prior epigenetic treatment did not alter inhibition of H358 colonies by gemcitabine or 17-AAG ...in response to 30 nM 17-AAG ... See full document
15
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
... the therapy fails ...immune therapy and interestingly relevant to this article, epigenetic therapies ...combinational therapy, con- sisting of PARP inhibitor and epigenetic ...the ... See full document
11
Epigenetics in cancer therapy and nanomedicine
... physiological response they elicit, such as cellular up- take, distribution bioavailability, and toxicity, and thus effectively generating a particle with a “ new biological identity ” ... See full document
18
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy
... – response assessment and demonstration of residual disease – and these goals may call for different MRI approaches that may be mutu- ally ...early response assessment may call for high temporal resolution ... See full document
16
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
... in response to experimentally induced seizures, in which hippocampal Bdnf and Fgf2 were both rapidly demethylated in a GADD45B-specific manner ...acute response to electrical stimulation, suggesting that ... See full document
13
<p>DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses</p>
... The two most classic drug classes used in epigenetic therapy are DNMTi and histone deacetylase inhibitors (HDACi). 27 DNMTs are key enzymes that catalyse DNA methylation, mainly DNMT1, DNMT3A, and DNMT3B. ... See full document
14
Predicting and modifying response to neoadjuvant therapy in colorectal cancer
... in response to neoadjuvant treatment, again there was heterogeneity between ...cellular response to chemotherapy, rather than the mechanism of action of the specific agents ...neoadjuvant therapy it ... See full document
394
Epigenetic therapy for ovarian cancer: promise and progress
... combining epigenetic and immune therapies: in a syngeneic ovarian cancer mouse model, a combination of decitabine and anti-CTLA-4 significantly reduced tumor growth and prolonged survival compared to each drug ... See full document
11
Epigenetic Tumor Response to Hypoxia: An Epimutation Pattern and a Method of Multi Targeted Epigenetic Therapy (MTET)
... ► 67-year-old female with history of a scalp birth mark that grew to a sizeable mass (2 cm) , with pathology of malignant melanoma diagnosed in 6/18/15 status post-surgical resection, pathology with positive (+) mar- ... See full document
16
The role of biomarkers in community acquired pneumonia: predicting mortality and response to adjunctive therapy
... inflammatory response syndrome criteria as a predictor of ...inflammatory response syndrome criteria and Standardized Early Warning Score in the initial prognostic assessment of patients with ... See full document
7
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
... Treatment of breast cancer includes locoregional resection, with or without radiotherapy as well as systemic therapies such as chemotherapy, endocrine therapy, biological tar- geting agents, and a combination of ... See full document
15
Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis
... personalised therapeutic protocols for those suffering from the disease. 5 Identifying these unique signatures could make a signi fi cant difference in RA management and attainment of disease remission. Metabolomics is ... See full document
9
Related subjects